Antiphospholipid Antibody Syndrome: Much Remains to be Learned

Lara C. Pullen, PhD, is a medical writer based in the Chicago area.

References

Buyon JP, Kim MY, Guerra MM, et al. Predictors of pregnancy outcome in a prospective, multiethnic cohort of lupus patients. Ann Intern Med. 2015 Aug 4;163(3):153–163.
Phialy L, Zuily S, Erkan D. (2016) Antiphospholipid Syndrome. Ed. Université de Lorraine—Faculté de médecine.
Barbhaiya M, Zuily S, Ahmadzadeh Y, et al. Development of new international classification criteria for antiphospholipid syndrome: Phase II item reduction survey (abstract 163). 2018 ACR/ARHP Annual Meeting.
Kearon C, Ginsberg JS, Anderson DR, et al. Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor. J Thromb Haemost. 2004 May;2(5):743–749.

The problem that dogs the work of all of those treating patients with antiphospholipid syndrome (APS) is the apparent lack of knowledge of the syndrome, both by the general public, as well as by swaths of the medical fraternity. Perhaps it was ever thus—a syndrome less than 40 years old could be described as new,…

Successes, challenges, and controversies of diagnostic methods for APS

With a wide range of clinical manifestations and frequent occurrence among rheumatology patients, APS is one for rheumatologists to watch

APS ACTION is coordinating international efforts to study this rare and potentially fatal autoimmune disorder

References

APS: What Rheumatologists Should Know about Hughes Syndrome

Antiphospholipid Antibody Testing Update

Why Antiphospholipid Antibody Syndrome Should Be On Your Radar

A Catalyst for Antiphospholipid Syndrome Research

References

Related Articles